-NDTV The Supreme Court has said that it will not hesitate in stopping the work at Kudankulam nuclear power plant if it finds that safety measures at the plant in Tamil Nadu are unsatisfactory. The court made these observations while hearing an appeal against the Madras High Court order that allowed fuel loading at the plant. A bench of justices K S Radhakrishanan and Deepak Misra said the safety of plant and...

-The Times of India A new scam worth several thousands of crores has come to light. The Central Bureau of Investigation has started a probe into serious irregularities in awarding offshore mining blocks to private companies which did not fulfill the eligibility criteria. The CBI has registered a preliminary enquiry (PE) against officials of the Indian Bureau of Mines (IBM), the ministry of mines as well as private companies which secured licences...

-Frontline Reinstatement of the fundamental right to property in the Constitution will on its own do little to protect the interests of poor peasants and traditional communities.  The Indian Constitution adopted in 1950 guaranteed a set of fundamental rights that cannot be abridged by Central or State laws. One of these fundamental rights was the right to property enshrined in Articles 19(1)(f) and 31. Article 19(1)(f) guaranteed to all citizens the right...

-The Indian Express A group of teachers at Jamia Milia Islamia University has put together a compilation of terror cases that failed to hold up in court, all of these built by the Delhi Police Special Cell around youths they had arrested and described as terrorists. Titled “Framed, Damned and Acquitted: Dossiers of a Very Special Cell” and compiled from court judgments and media reports, the study by the Jamia Teachers’ Solidarity...

-The Economic Times MUMBAI: In a victory to generic drugmakers, the Intellectual Property Appellate Board (IPAB) of Chennai has dismissed German pharma major Bayer's plea, seeking a stay on the Compulsory Licence issued to Hyderabad-based drugmaker Natco. The Compulsory Licence (CL) issued by the Controller of Patents in March this year allowed Natco to make and sell a generic version of Nexavar - used for treating liver and kidney cancer - at...